Phase 2 Trial of Continuous Course Re-irradiation Concurrent With Weekly Cisplatinum and Cetuximab for Recurrent Squamous Cell Carcinoma of the Head and Neck: Preliminary Report
2014 ◽
Vol 90
(1)
◽
pp. S179
2015 ◽
Vol 91
(3)
◽
pp. 480-488
◽